Business Context and Reporting Period
Marvell Technology, Inc. filed this Form 8-K under Item 8.01 on April 29, 2021, with the report signed May 3, 2021. The filing concerns a privately negotiated exchange of Inphi Corporation convertible notes following Marvell’s completion of its acquisition of Inphi on April 20, 2021.
Transaction and Key Financial Information
- Inphi, a wholly owned subsidiary of Marvell, issued 7,115,085 newly issued Marvell common shares to a limited number of noteholders.
- The shares were exchanged for approximately $9.6 million of aggregate principal amount of Inphi’s 0.75% Convertible Senior Notes due 2021 and $199.5 million of aggregate principal amount of Inphi’s 0.75% Convertible Senior Notes due 2025.
- The exchanged notes were cancelled upon settlement on April 29, 2021.
- The transaction reduces the specified Inphi note principal outstanding by approximately $209.1 million and increases Marvell’s shares outstanding through the issuance of the Exchange Shares.
- The filing does not provide revenue, profit, cash flow, margin, total debt, liquidity, or other operating results for a reporting period.
Material Changes Versus the Prior Comparable Period
This is a transaction-focused Form 8-K and does not present comparative financial statements or prior-period operating results. The material changes disclosed are the cancellation of the exchanged notes and the issuance of 7,115,085 Marvell common shares in connection with the Inphi acquisition.
Offering Terms, Outlook, and Risks
- The Exchange Shares were issued under the private-placement exemption in Section 4(a)(2) of the Securities Act and have not been registered under federal or state securities laws.
- Marvell does not intend to file a resale registration statement for the Exchange Shares.
- The filing provides no quantitative earnings guidance or other financial outlook.
- Risks include failure to realize anticipated acquisition benefits, integration costs or delays, retention of key personnel, adverse effects on business relationships, third-party consent requirements, supply-chain disruptions, COVID-19 and other public-health impacts, regulatory and tax developments, economic and market conditions, and catastrophic events.
Facts Investors Should Verify
- Confirm the final number of Marvell common shares outstanding after issuance of the 7,115,085 Exchange Shares.
- Verify the remaining principal balance and terms of Inphi’s 2021 and 2025 convertible notes after cancellation of the exchanged notes.
- Review subsequent filings for the accounting treatment and dilution impact of the exchange and the completed Inphi acquisition.
- Assess Marvell’s reported integration costs, synergies, debt, liquidity, and operating performance in subsequent quarterly filings.
- Review the acquisition-related risk factors in Marvell’s filings, including integration, supply-chain, regulatory, and macroeconomic risks.